Clinical Trial Update: An Evaluation of the Long-term Efficacy and Safety of Methylone for the Treatment of PTSD [Phase 2]

View source ↗

Summary

This Phase 2 trial update reports the long-term efficacy and safety results of methylone for Post-Traumatic Stress Disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-traumatic Stress Disorder

Drugs mentioned

• Methylone (3,4-methylenedioxy-N-methylcathinone)

Snippet

Sponsor: Transcend Therapeutics | Conditions: Post Traumatic Stress Disorder | Phase 2 | Status: COMPLETED